RXi Pharmaceutics extends runway in Q2

Despite reporting just $58,000 in second-quarter revenues, Marlborough drugmaker RXi Pharmaceuticals was able to significantly reduce its net loss, reduce its cash burn and extend its runway.

ReWalk shares dive 19% after lackluster earnings report

Shares of Marlborough medical device maker ReWalk Robotics dropped 19 percent at Tuesday’s open after the company reported a second quarter loss of $5.8 million with $9.1 million in cash left...

Worcester State, Nichols form counter-terrorism degree agreement

Worcester State University criminal justice majors will be able to get a master's degree in counter-terrorism a year ahead of time under a new agreement with Nichols College in Dudley.

FDA warns Hologic over device's vaginal rejuvenation claims

Marlborough medical device company Hologic is suspending the marketing and distribution of a vaginal heating device after the company receiving a warning from the U.S. Food and Drug Administration.

Biostage to withdraw SEC registration

Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement.

Hopkinton biopharmaceutical Spring Bank hopes to raise $37.5M

Hopkinton-based Spring Bank Pharmaceuticals wants to raise $37.5 million to fund clinical trials, studies and research and other corporate purposes.

UMass Memorial offering first Worcester child eye surgery

UMass Memorial Medical Center is offering what it says is the first child eye surgery unit in Worcester in a new collaboration with Boston Children's Hospital.

Data storage company closing 114-worker Marlborough facility

The data storage company Western Digital is closing a 114-worker facility in Marlborough as part of a restructuring.